cardiolipina

Cardiolipin is a unique phospholipid found predominantly in the inner mitochondrial membrane of eukaryotic cells, particularly in high concentrations in the heart and skeletal muscle. Structurally distinct from other phospholipids, cardiolipin consists of four fatty acid chains attached to a glycerol backbone, forming a tetra-acyl structure. This configuration contributes to its role in maintaining mitochondrial function and stability.

Synthesized primarily during periods of rapid cell growth, such as in developing tissues or after cellular injury, cardiolipin is essential for the proper assembly and function of the electron transport chain complexes, particularly Complex I and IV. Its presence helps stabilize these complexes within the mitochondrial membrane, facilitating efficient ATP production through oxidative phosphorylation. Additionally, cardiolipin plays a role in membrane curvature, protein interactions, and the regulation of apoptosis.

Cardiolipin is also involved in immune responses, as its oxidation products can act as damage-associated molecular patterns (DAMPs), triggering inflammatory responses. In autoimmune diseases like systemic lupus erythematosus (SLE), antibodies against cardiolipin—known as antiphospholipid antibodies—can form, leading to complications such as thrombosis and pregnancy-related disorders.

Biochemically, cardiolipin can undergo oxidative modifications, which may impair mitochondrial function and contribute to aging or disease progression. Research into cardiolipin’s role in health and disease continues, exploring its potential as a therapeutic target in conditions involving mitochondrial dysfunction, such as neurodegenerative disorders and cardiovascular diseases.